EyeGate Pharmaceuticals, Inc. - EYEG - Fundamentals

Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Insider Tracker is here!

Try it now Watch the presentation

‌
‌

‌

Let's get started...

‌

Breakdown	2012 12/31	2013 12/31	2014 12/31	2015 12/31	2016 12/31	2017 12/31	2018 12/31	2019 12/31	2020 12/31	2024 12/31	2025 12/31	TTM
REVENUE	0	0	0	0	1	0	2	3	0	16	0	--	📊
Revenue Growth (1Y)	--	--	--	--	--	-39.11%	+305.51%	+62.54%	-99.55%	+132746.84%	-100.00%	--	📊
Revenue Growth (5Y)	--	--	--	--	--	--	--	--	-98.20%	+3831.11%	-100.00%	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	--	--	-100.00%	📊
Cost of Revenue	0	0	0	0	0	0	0	0	0	0	0	--	📊
Cost of Revenue Growth (1Y)	--	--	--	--	--	--	--	--	--	-100.00%	--	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Gross Profit	0	0	0	0	1	0	2	3	0	16	0	--	📊
Gross Profit Growth (1Y)	--	--	--	--	--	-39.11%	+305.51%	+62.54%	-100.00%	+123230669.23%	-100.00%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	--	--	--	--	-100.00%	+3831.11%	-100.00%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	--	--	-100.00%	📊
Operating Expenses	6	3	2	7	14	15	12	10	8	13	17	16	📊
Operating Expenses Growth (1Y)	--	-47.06%	-20.52%	+171.22%	+109.90%	+6.78%	-16.50%	-21.62%	-16.03%	+62.73%	+23.47%	-4.65%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+139.50%	+383.13%	+407.59%	+46.68%	-41.32%	-10.57%	+32.23%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	+128.71%	+433.44%	+12.42%	📊
Sell General Administrative	3	2	2	4	6	5	4	4	5	6	6	6	📊
Research and Development	3	1	1	3	8	10	8	5	4	8	11	10	📊
Other Income Expenses	0	0	0	0	0	0	0	0	0	0	0	--	📊
EBITDA	-6	-3	-1	-6	-13	-15	-11	-7	-8	0	0	5	📊
EBITDA Growth (1Y)	--	+45.85%	+59.22%	-385.32%	-106.55%	-9.01%	+26.50%	+36.49%	-18.49%	+100.00%	--	--	📊
EBITDA Growth (5Y)	--	--	--	--	-121.38%	-345.64%	-703.12%	-5.10%	+39.70%	+100.00%	+100.00%	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	+100.00%	+100.00%	+135.44%	📊
Depreciation and Amortization	0	0	0	0	0	0	0	0	0	0	0	--	📊
Operating Income	-6	-3	-2	-7	-13	-15	-11	-7	-8	3	0	5	📊
Operating Income Growth (1Y)	--	+47.06%	+20.52%	-171.22%	-99.87%	-9.08%	+25.51%	+34.45%	-15.53%	+132.09%	-100.00%	--	📊
Operating Income Growth (5Y)	--	--	--	--	-128.06%	-369.97%	-340.47%	-6.46%	+38.47%	+118.10%	+100.00%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	+145.03%	+100.00%	+135.41%	📊
Interest Expense	0	1	0	2	0	0	0	0	0	-0	-0	--	📊
Pre Tax Income	-6	-4	-2	-8	-13	-15	-11	-7	-8	6	-12	-12	📊
Tax Provision	0	0	1	0	0	-1	0	0	0	-2	1	1	📊
NET INCOME	-6	-4	-2	-8	-13	-13	-11	-7	-8	8	-11	-11	📊
Net Income Growth (1Y)	--	+35.71%	+54.27%	-373.12%	-58.98%	+0.94%	+18.21%	+34.36%	-14.02%	+195.46%	-240.27%	-1.40%	📊
Net Income Growth (5Y)	--	--	--	--	-121.13%	-240.72%	-509.44%	+15.45%	+39.36%	+158.44%	-0.22%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	+228.02%	-179.30%	+17.66%	📊
Basic EPS	-469.29	-11.62	-3.83	-18.14	-22.66	-13.9	-4.57	-2.23	-2.54	1.99	-2.6	-2.46	📊
Diluted EPS	-469.29	-11.62	-3.83	-18.14	-22.66	-13.9	-4.57	-2.23	-2.54	1.87	-2.64	-2.5	📊
Basic Average Shares	0	0	0	0	1	1	2	3	3	4	4	5	📊
Diluted Average Shares	0	0	0	0	1	1	2	3	3	4	4	5	📊

Breakdown

2012

12/31

2013

12/31

2014

12/31

2015

12/31

2016

12/31

2017

12/31

2018

12/31

2019

12/31

2020

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

-39.11%

+305.51%

+62.54%

-99.55%

+132746.84%

-100.00%

📊

Revenue Growth (5Y)

-98.20%

+3831.11%

-100.00%

📊

Revenue Growth (10Y)

-100.00%

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

-100.00%

📊

Cost of Revenue Growth (5Y)

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

📊

Gross Profit Growth (1Y)

-39.11%

+305.51%

+62.54%

-100.00%

+123230669.23%

-100.00%

📊

Gross Profit Growth (5Y)

-100.00%

+3831.11%

-100.00%

📊

Gross Profit Growth (10Y)

-100.00%

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

-47.06%

-20.52%

+171.22%

+109.90%

+6.78%

-16.50%

-21.62%

-16.03%

+62.73%

+23.47%

-4.65%

📊

Operating Expenses Growth (5Y)

+139.50%

+383.13%

+407.59%

+46.68%

-41.32%

-10.57%

+32.23%

📊

Operating Expenses Growth (10Y)

+128.71%

+433.44%

+12.42%

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

📊

EBITDA

-6

-3

-1

-6

-13

-15

-11

-7

-8

📊

EBITDA Growth (1Y)

+45.85%

+59.22%

-385.32%

-106.55%

-9.01%

+26.50%

+36.49%

-18.49%

+100.00%

📊

EBITDA Growth (5Y)

-121.38%

-345.64%

-703.12%

-5.10%

+39.70%

+100.00%

📊

EBITDA Growth (10Y)

+100.00%

+135.44%

📊

Depreciation and Amortization

📊

Operating Income

-6

-3

-2

-7

-13

-15

-11

-7

-8

📊

Operating Income Growth (1Y)

+47.06%

+20.52%

-171.22%

-99.87%

-9.08%

+25.51%

+34.45%

-15.53%

+132.09%

-100.00%

📊

Operating Income Growth (5Y)

-128.06%

-369.97%

-340.47%

-6.46%

+38.47%

+118.10%

+100.00%

📊

Operating Income Growth (10Y)

+145.03%

+100.00%

+135.41%

📊

Interest Expense

-0

📊

Pre Tax Income

-6

-4

-2

-8

-13

-15

-11

-7

-8

-12

📊

Tax Provision

-1

-2

📊

NET INCOME

-6

-4

-2

-8

-13

-11

-7

-8

-11

📊

Net Income Growth (1Y)

+35.71%

+54.27%

-373.12%

-58.98%

+0.94%

+18.21%

+34.36%

-14.02%

+195.46%

-240.27%

-1.40%

📊

Net Income Growth (5Y)

-121.13%

-240.72%

-509.44%

+15.45%

+39.36%

+158.44%

-0.22%

📊

Net Income Growth (10Y)

+228.02%

-179.30%

+17.66%

📊

Basic EPS

-469.29

-11.62

-3.83

-18.14

-22.66

-13.9

-4.57

-2.23

-2.54

1.99

-2.6

-2.46

📊

Diluted EPS

-469.29

-11.62

-3.83

-18.14

-22.66

-13.9

-4.57

-2.23

-2.54

1.87

-2.64

-2.5

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Breakdown	2012 12/31	2013 12/31	2014 12/31	2015 12/31	2016 12/31	2017 12/31	2018 12/31	2019 12/31	2020 12/31	2024 12/31	2025 12/31	TTM
REVENUE	0	0	0	0	1	0	2	3	0	16	0	--	📊
Revenue Growth (1Y)	--	--	--	--	--	-39.11%	+305.51%	+62.54%	-99.55%	+132746.84%	-100.00%	--	📊
Revenue Growth (5Y)	--	--	--	--	--	--	--	--	-98.20%	+3831.11%	-100.00%	--	📊
Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	--	--	-100.00%	📊
Cost of Revenue	0	0	0	0	0	0	0	0	0	0	0	--	📊
Cost of Revenue Growth (1Y)	--	--	--	--	--	--	--	--	--	-100.00%	--	--	📊
Cost of Revenue Growth (5Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Cost of Revenue Growth (10Y)	--	--	--	--	--	--	--	--	--	--	--	--	📊
Gross Profit	0	0	0	0	1	0	2	3	0	16	0	--	📊
Gross Profit Growth (1Y)	--	--	--	--	--	-39.11%	+305.51%	+62.54%	-100.00%	+123230669.23%	-100.00%	--	📊
Gross Profit Growth (5Y)	--	--	--	--	--	--	--	--	-100.00%	+3831.11%	-100.00%	--	📊
Gross Profit Growth (10Y)	--	--	--	--	--	--	--	--	--	--	--	-100.00%	📊
Operating Expenses	6	3	2	7	14	15	12	10	8	13	17	16	📊
Operating Expenses Growth (1Y)	--	-47.06%	-20.52%	+171.22%	+109.90%	+6.78%	-16.50%	-21.62%	-16.03%	+62.73%	+23.47%	-4.65%	📊
Operating Expenses Growth (5Y)	--	--	--	--	+139.50%	+383.13%	+407.59%	+46.68%	-41.32%	-10.57%	+32.23%	--	📊
Operating Expenses Growth (10Y)	--	--	--	--	--	--	--	--	--	+128.71%	+433.44%	+12.42%	📊
Sell General Administrative	3	2	2	4	6	5	4	4	5	6	6	6	📊
Research and Development	3	1	1	3	8	10	8	5	4	8	11	10	📊
Other Income Expenses	0	0	0	0	0	0	0	0	0	0	0	--	📊
EBITDA	-6	-3	-1	-6	-13	-15	-11	-7	-8	0	0	5	📊
EBITDA Growth (1Y)	--	+45.85%	+59.22%	-385.32%	-106.55%	-9.01%	+26.50%	+36.49%	-18.49%	+100.00%	--	--	📊
EBITDA Growth (5Y)	--	--	--	--	-121.38%	-345.64%	-703.12%	-5.10%	+39.70%	+100.00%	+100.00%	--	📊
EBITDA Growth (10Y)	--	--	--	--	--	--	--	--	--	+100.00%	+100.00%	+135.44%	📊
Depreciation and Amortization	0	0	0	0	0	0	0	0	0	0	0	--	📊
Operating Income	-6	-3	-2	-7	-13	-15	-11	-7	-8	3	0	5	📊
Operating Income Growth (1Y)	--	+47.06%	+20.52%	-171.22%	-99.87%	-9.08%	+25.51%	+34.45%	-15.53%	+132.09%	-100.00%	--	📊
Operating Income Growth (5Y)	--	--	--	--	-128.06%	-369.97%	-340.47%	-6.46%	+38.47%	+118.10%	+100.00%	--	📊
Operating Income Growth (10Y)	--	--	--	--	--	--	--	--	--	+145.03%	+100.00%	+135.41%	📊
Interest Expense	0	1	0	2	0	0	0	0	0	-0	-0	--	📊
Pre Tax Income	-6	-4	-2	-8	-13	-15	-11	-7	-8	6	-12	-12	📊
Tax Provision	0	0	1	0	0	-1	0	0	0	-2	1	1	📊
NET INCOME	-6	-4	-2	-8	-13	-13	-11	-7	-8	8	-11	-11	📊
Net Income Growth (1Y)	--	+35.71%	+54.27%	-373.12%	-58.98%	+0.94%	+18.21%	+34.36%	-14.02%	+195.46%	-240.27%	-1.40%	📊
Net Income Growth (5Y)	--	--	--	--	-121.13%	-240.72%	-509.44%	+15.45%	+39.36%	+158.44%	-0.22%	--	📊
Net Income Growth (10Y)	--	--	--	--	--	--	--	--	--	+228.02%	-179.30%	+17.66%	📊
Basic EPS	-469.29	-11.62	-3.83	-18.14	-22.66	-13.9	-4.57	-2.23	-2.54	1.99	-2.6	-2.46	📊
Diluted EPS	-469.29	-11.62	-3.83	-18.14	-22.66	-13.9	-4.57	-2.23	-2.54	1.87	-2.64	-2.5	📊
Basic Average Shares	0	0	0	0	1	1	2	3	3	4	4	5	📊
Diluted Average Shares	0	0	0	0	1	1	2	3	3	4	4	5	📊

Breakdown

2012

12/31

2013

12/31

2014

12/31

2015

12/31

2016

12/31

2017

12/31

2018

12/31

2019

12/31

2020

12/31

2024

12/31

2025

12/31

TTM

REVENUE

📊

Revenue Growth (1Y)

-39.11%

+305.51%

+62.54%

-99.55%

+132746.84%

-100.00%

📊

Revenue Growth (5Y)

-98.20%

+3831.11%

-100.00%

📊

Revenue Growth (10Y)

-100.00%

📊

Cost of Revenue

📊

Cost of Revenue Growth (1Y)

-100.00%

📊

Cost of Revenue Growth (5Y)

📊

Cost of Revenue Growth (10Y)

📊

Gross Profit

📊

Gross Profit Growth (1Y)

-39.11%

+305.51%

+62.54%

-100.00%

+123230669.23%

-100.00%

📊

Gross Profit Growth (5Y)

-100.00%

+3831.11%

-100.00%

📊

Gross Profit Growth (10Y)

-100.00%

📊

Operating Expenses

📊

Operating Expenses Growth (1Y)

-47.06%

-20.52%

+171.22%

+109.90%

+6.78%

-16.50%

-21.62%

-16.03%

+62.73%

+23.47%

-4.65%

📊

Operating Expenses Growth (5Y)

+139.50%

+383.13%

+407.59%

+46.68%

-41.32%

-10.57%

+32.23%

📊

Operating Expenses Growth (10Y)

+128.71%

+433.44%

+12.42%

📊

Sell General Administrative

📊

Research and Development

📊

Other Income Expenses

📊

EBITDA

-6

-3

-1

-6

-13

-15

-11

-7

-8

📊

EBITDA Growth (1Y)

+45.85%

+59.22%

-385.32%

-106.55%

-9.01%

+26.50%

+36.49%

-18.49%

+100.00%

📊

EBITDA Growth (5Y)

-121.38%

-345.64%

-703.12%

-5.10%

+39.70%

+100.00%

📊

EBITDA Growth (10Y)

+100.00%

+135.44%

📊

Depreciation and Amortization

📊

Operating Income

-6

-3

-2

-7

-13

-15

-11

-7

-8

📊

Operating Income Growth (1Y)

+47.06%

+20.52%

-171.22%

-99.87%

-9.08%

+25.51%

+34.45%

-15.53%

+132.09%

-100.00%

📊

Operating Income Growth (5Y)

-128.06%

-369.97%

-340.47%

-6.46%

+38.47%

+118.10%

+100.00%

📊

Operating Income Growth (10Y)

+145.03%

+100.00%

+135.41%

📊

Interest Expense

-0

📊

Pre Tax Income

-6

-4

-2

-8

-13

-15

-11

-7

-8

-12

📊

Tax Provision

-1

-2

📊

NET INCOME

-6

-4

-2

-8

-13

-11

-7

-8

-11

📊

Net Income Growth (1Y)

+35.71%

+54.27%

-373.12%

-58.98%

+0.94%

+18.21%

+34.36%

-14.02%

+195.46%

-240.27%

-1.40%

📊

Net Income Growth (5Y)

-121.13%

-240.72%

-509.44%

+15.45%

+39.36%

+158.44%

-0.22%

📊

Net Income Growth (10Y)

+228.02%

-179.30%

+17.66%

📊

Basic EPS

-469.29

-11.62

-3.83

-18.14

-22.66

-13.9

-4.57

-2.23

-2.54

1.99

-2.6

-2.46

📊

Diluted EPS

-469.29

-11.62

-3.83

-18.14

-22.66

-13.9

-4.57

-2.23

-2.54

1.87

-2.64

-2.5

📊

Basic Average Shares

📊

Diluted Average Shares

📊

Ex-Dividend date
Payment date
Annual Dividend	1.58 ($)
Dividend Yield	4.64%
Shareholders Yield	0.04%
Next Earnings	--
Market cap	210.54M (USD)
EPS (TTM)	-2.46 ($)
P/E (TTM)	-13.85 ($)
Last Close	34.08

Next Earnings	--
Market cap	210.54M (USD)
EPS (TTM)	-2.46 ($)
P/E (TTM)	-13.85 ($)
Last Close	34.08 ($)

Ex-Dividend date
Payment date
Annual Dividend	1.58 ($)
Dividend Yield	4.64%
Shareholders Yield	0.04%
Next Earnings	--
Market cap	210.54M (USD)
EPS (TTM)	-2.46 ($)
P/E (TTM)	-13.85 ($)
Last Close	34.08

Next Earnings	--
Market cap	210.54M (USD)
EPS (TTM)	-2.46 ($)
P/E (TTM)	-13.85 ($)
Last Close	34.08 ($)